CytoDyn (OTCQB:CYDY) will host a conference call on Wednesday, September 2, at 4:00 pm ET to update investors on all of its regulatory and clinical initiatives including its activities related to leronlimab in COVID-19.
CEO Nader Pourhassan, Ph.D., Chairman, CMO and Head of Business Development Scott Kelly, M.D. and Chief Science Advisor Jacob Lalezari, M.D. will host.
Management will allocate ~45 minutes for Q&A.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.